Get started
Award

C5047/A10692

Funded outputs count: 36
Funder award ID: C5047/A10692
OpenAlex ID: G4806032448
Circulating Inflammatory Markers and Mammographic Density Phenotypes: a Mendelian Randomization Analysis
2026 · Austin Hammermeister Suger, Tabitha A. Harrison, et al. · medRxiv
Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation
2026 · Tessa Bate, Mei Dong, et al. · Research Square
PDF
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups
2026 · Hagai Levi, Qin Wang, et al. · medRxiv
PDF
Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis
2026 · Nasim Mavaddat, Daniel R. Barnes, et al. · British Journal of Cancer
PDF
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
2026 · Jason L. Vassy, Anna M. Dornisch, et al. · Nature Cancer · 8
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics
2024 · Trishna A. Desai, Åsa K. Hedman, et al. · EBioMedicine · 27
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2024 · Clarke, C.L., Anton-Culver, H., et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2024 · Koutros, S., Janni, W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
2024 · Manoukian, S., Ramachandran, D., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Unravelling the Role of Iroquois Homeobox 4 and its Interplay with Androgen Receptor in Prostate Cancer
2023 · Jyotsna Batra, Janaththani Panchadsaram, et al. · Research Square · 1
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
2023 · Kote-Jarai, Z., The PRACTICAL Consortium, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study
2023 · Chaoran Ma, Xiaoyu Wang, et al. · Cancer Epidemiology Biomarkers & Prevention · 3
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
2023 · Sara Lindström, Lu Wang, et al. · JNCI Journal of the National Cancer Institute · 31
PDF
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
2023 · Stefanie H. Mueller, Alvina G. Lai, et al. · Genome Medicine · 15
PDF
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 29
PDF
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
2022 · Brandao A, Paulo P, et al. · UTUPub (University of Turku)
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2022 · Suzanne C Dixon-Suen, Sarah J Lewis, et al. · British Journal of Sports Medicine · 88
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity
2022 · Gillian C. Barnett, Sarah L. Kerns, et al. · International Journal of Radiation Oncology*Biology*Physics · 7
PDF
Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study
2022 · Fernanda Morales-Berstein, Daniel L McCartney, et al. · eLife · 86
Rare germline copy number variants (CNVs) and breast cancer risk
2022 · Joe Dennis, Jonathan P. Tyrer, et al. · Communications Biology · 15
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2021 · Anna Morra, Maria Escala-Garcia, et al. · Breast Cancer Research · 22
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
2021 · Morra, Anna, Escala-Garcia, Maria, et al. · Apollo (University of Cambridge)
PDF
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
2021 · JooYong Park, Ji-Yeob Choi, et al. · Cancers · 9
PDF
Year
Topic